Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
1,869,472
-
Share change
-
+442,048
-
Total reported value
-
$90,061,576
-
Price per share
-
$45.71
-
Number of holders
-
77
-
Value change
-
+$20,195,651
-
Number of buys
-
47
-
Number of sells
-
16
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q1 2021
As of 31 Mar 2021,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,869,472 shares.
The largest 10 holders included
UBS Group AG, JANE STREET GROUP, LLC, Thrivent Financial for Lutherans, BANK OF AMERICA CORP /DE/, Wharton Business Group, LLC, LPL Financial LLC, ROYAL BANK OF CANADA, Wealthcare Advisory Partners LLC, RETIREMENT CAPITAL STRATEGIES, and Sharkey, Howes & Javer.
This page lists
77
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.